Abstract
Older patients suffer from a variety of conditions that affect the hair, i.e. nutritional deficiency, endocrine disorders, psychologic problems, and drug-related adverse effects. The quantity and quality of hair are closely related to the nutritional, general, and mental health state of the individual. Sometimes, symptoms of overt pathologic conditions are misinterpreted as signs of normal aging, ignored and left untreated. In taking care of older patients with hair problems, it is therefore important to be suspicious of the possibility of a more general problem underlying the patient’s complaint. The increasing number of chronic conditions per patient and the increasing amount of multimorbidity in the elderly population lead to a more complex approach to successful therapy of hair problems in the elderly.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abadjieva TI (2000) Treatment of androgenetic alopecia in females in reproductive age with topical estradiolbenzoate, prednisolon and salicylic acid. Folia Med (Plovdiv) 42(3): 26–29
Ahrens J (1994) Systemische Behandlung des diffusen Haarausfalls. Therapiewoche Schweiz 10:551–554
Anderson GL, Limacher M, Assaf AR et al (2004) Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women’s Health Initiative randomized controlled trial. JAMA 291 (14):1701–1712
Aydingoz I, Ferhanoglu B, Guney O (1999) Does tissue iron status have a role in female alopecia? J Eur Acad Dermatol Venereol 13:65–67
Baker B, Wilson C, Davis A et al (1991) Busulphan/cyclophosphamide conditioning for bone marrow transplantation may lead to failure of hair regrowth. Bone Marrow Transpl 7:43–47
Batchelor D (2001) Hair and cancer chemotherapy: consequences and nursing care - a literature study. Eur J Cancer Care 10:147–163
Billoni N, Buan B, Gautier B, Gaillard O, Mahé YF, Bernard BA (2000) Thyroid hormone receptor beta1 is expressed in the human hair follicle. Br J Dermatol 142(4):645–652
Blume-Peytavi U, Kunte C, Krisp A, Garcia Bartels N, Ellwanger U, Hoffmann R (2007) Comparison of the efficacy and safety of topical minoxidil and topical alfatradiol in the treatment of androgenetic alopecia in women. J Dtsch Dermatol Ges 5(5):391–395
Bodenheimer T (1999) Disease management: promises and pitfalls. N Engl J Med 340(15):1202–1205
Braun-Falco O, Vogel PG (1968) Trichotemnomanie. Eine besondere Manifestation eines hirnorganischen Psychosyndroms. Hautarzt 19:551–553
Bregy A, Trueb RM (2008) No association between serum ferritin levels > 10 microg/l and hair loss activity in women. Dermatology 217(1):1–6
Brosig B, Kupfer J, Niemeier V, Gieler U (2001) The “Dorian Gray Syndrome”: psychodynamic need for hair growth restorers and other “fountains of youth.” Int J Clin Pharmacol Ther 39:279–283
Brown WT, Kieras FJ, Houck GE Jr, Dutkowski R, Jenins ECA (1985) Comparison of adult and childhood progerias: Werner syndrome and Hutchinson-Gilford progeria syndrome. In: Salk D, Fujwara Y, Martin GM (eds) Werner’s syndrome and human aging. Plenum Press, New York, pp 229–244
Budde J, Tronnier H, Rahlfs VW, Frei-Kleiner S (1993) Systemische Therapie von diffusem Effluvium und Haarstrukturschäden. Hautarzt 44:380–384
Buhl AE, Waldon DJ, Kawabe TT et al (1989) Minoxidil stimulates mouse vibrissae follicles in organ culture. J Invest Dermatol 92:315–320
Carlini P, Di Cosimo S, Ferretti G, Papaldo P, Fabi A, Ruggeri EM, Milella M, Cognetti F (2003) Alopecia in a premenopausal breast cancer woman treated with letrozole and triptorelin. Ann Oncol 14(11):1689–1690
Carter JN, Tyson JE, Warne GL, McNeilly AS, Faiman C, Friesen HG (1977) Adrenocortical function in hyperprolactinemic women. J Clin Endocrinol Metab 45(5):973–980
Centers for Disease Control (CDC) (1998) Recommendations to prevent and control iron deficiency in the Unites States. Morb Mortal Wkly Rep 47:1–36
Centers for Disease Control (CDC) (2002) Iron deficiency – United States, 1999–2000. Morb Mortal Wkly Rep 51: 897–899
Chein E (1998) Age reversal, from hormones to telomeres. WorldLink Medical Publishing
Cormia FE (1967) Alopecia from oral contraceptives. JAMA 201:635–637
D’Agostini F, Fiallo P, Pennisi TM, De Flora S (2007) Chemoprevention of smoke-induced alopecia in mice by oral administration of L-cystine and vitamin B6. J Dermatol Sci 46:189–198
Daveluy C, Pica L, Audet N, Courtemanche R, Lapointe F (2000) Enquête sociale et de santé 1998, 2nd ed. Institut de la statistique du Québec, Quebec
Dorr VJ (1998) A practioner’s guide to cancer-related alopecia. Semin Oncol 25:562–570
Fabisch W (1980) Psychiatric aspects of dermatitis artefacta. Br J Dermatol 102:29–34
Fischer TW, Burmeister G, Schmidt HW, Elsner P (2004) Melatonin increases anagen hair rate in women with androgenetic alopecia or diffuse alopecia: results of a pilot randomized controlled trial. Br J Dermatol 150(2):341–345
Fischer TW, Slominski A, Tobin DJ, Paus R (2008) Melatonin and the hair follicle. J Pineal Res 44(1):1–15
Frenkel MJ, Gillepsie JM, Reis PJ (1974) Factors influencing the biosynthesis of the tyrosine-rich proteins of wool. Aust J Biol Sci 27:31–38
Freyschmidt-Paul P, Hoffmann R, Happle R (2001) Trichoteiromanie. Eur J Dermatol 11:369–371
Gandy DT (1953) The concept and clinical aspects of factitious dermatitis. South Med J 46:551–555
Gehring W, Gloor M (2000) Das Phototrichogramm als Verfahren zur Beurteilung haarwachstumsfördernder Präparate am Beispiel einer Kombination von Hirsefruchtextrakt, L-Cystin und Calciumpantothenat. Z Hautkr 75: 419–423
Georgala S, Katoulis AC, Georgala C, Moussatou V, Bozi E, Stavrianeas NG (2004) Topical estrogen therapy for androgenetic alopecia in menopausal females. Dermatology 208(2):178–179
Gillespie JM, Reis PJ (1966) Dietary regulated biosynthesis of high-sulfur wool proteins. Biochem J 98:669–677
Grevelman EG, Breed WPM (2005) Prevention of chemotherapy-induced hair loss by scalp cooling. Annals Oncol 16:352–358
Guzzetta F (1972) Cockayne-Neill-Dingwall syndrome. In: Vincken PJ, Bruyn GW (eds) Handbook of clinical neurology, vol 13. North Holland, Amsterdam, pp 431–440
Hard S (1963) Non-anemic iron deficiency as an etiologic factor in diffuse loss of hair of the scalp in women. Acta Derm Venereol 43:562–569
Hollender MH, Abram HS (1973) Dermatitis factitia. South Med J 66:1279–1285
Holman H, Lorig K (2000) Patients as partners in managing chronic disease. Partnership is a prerequisite for effective and efficient health care. BMJ 320(7234):526–527
Jackson D, Church RE, Ebling FJ (1972) Hair diameter in female baldness. Br J Dermatol 87(4):361–367
Johnson KA, Bernard MA, Funderberg K (2002) Vitamin nutrition in older adults. Clin Geriatr Med 18:773–799
Kantor J, Kessler LJ, Brooks DG, Cotsarelis G (2003) Decreased serum ferritin is associated with alopecia in women. J Invest Dermatol 121:985–988
Koo J (1995) Psychodermatology: a practical manual for clinicians. Curr Probl Dermatol VII (6):199–234
Lengg N, Heidecker B, Seifert B, Trüeb RM (2007) Dietary supplement increases anagen hair rate in women with telogen effluvium: results of a double-blind placebo-controlled trial. Therapy 4:59–65
Lurie R, Ben-Amitai D, Laron Z (2004) Laron syndrome (primary growth hormone insensitivity): a unique model to explore the effect of insulin-like growth factor 1 deficiency on human hair. Dermatology 208:314–318
Lyell A (1979) Cutaneous artifactual disease. A review amplified by personal experience. J Am Acad Dermatol 1:391–407
Lyell A (1983) Delusions of parasitosis. Br J Dermatol 108:485–499
Lynfield YL (1960) Effect of pregnancy on the human hair cycle. J Invest Dermatol 35:323–327
Macieira-Coelho A (2003) Biology of aging. Progress in molecular and subcellular biology. Springer, Heidelberg, pp 50–52
Marneros A, Rohde A, Deister A (1987) Most delusional parasitosis are organic mental disease. Clin Psych News 15:23
McGarvey EL, Baum LD, Pinkerton RC, Rogers LM (2001) Psychological sequelae and alopecia among women with cancer. Cancer Pract 9:283–289
Mills RG, Weiss AS (1990) Does progeria provide the best model of accelerated ageing in humans? Gerontology 36: 84–98
Mundstedt K, Manthey N, Sachsse S, Vahrson H (1997) Changes in self-concept and body image during alopecia induced cancer chemotherapy. Support Care Cancer 5:139–143
Ohnemus U, Uenalan M, Conrad F, Handjiski B, Mecklenburg L, Nakamura M, Inzunza J, Gustafsson JA, Paus R (2005) Hair cycle control by estrogens: catagen induction via estrogen receptor (ER)-alpha is checked by ER beta signaling. Endocrinology 146(3):1214–1225
Ohnemus U, Uenalan M, Inzunza J, Gustafsson JA, Paus R (2006) The hair follicle as an estrogen target and source. Enodcr Rev 27(6):677–706
Orfanos CE, Hertel H (1988) Disorder of hair growth in hyperprolactinemia. Z Hautkr 63(1):23–26
Orfanos CE, Vogels L (1980) Local therapy of androgenetic alopecia with 17 alpha-estradiol. A controlled, randomized double-blind study. Dermatologica 161(2):124–132
Pavlou M, Stefoski D (1983) Development of somatizing responses in multiple sclerosis. Psychother Psychosom 39:236–243
Pecoraro V, Barman JM, Astoe I (1969) The normal trichogram of pregnant women. In: Montagna W, Dobson RL (eds) Advances in biology of skin, vol IX, hair growth. Pergamon Press, Oxford, p 203
Petri H, Perchalla P, Tronnier H (1990) Die Wirksamkeit einer medikamentösen Therapie bei Haarstrukturschäden und diffusen Effluvien – vergleichende Doppelblindstudie. Schweiz Rundsch Med Prax 79:1457–1462
Phillips TJ, Demarcay Z, Sahu M (2001) Hormonal effects on skin aging. Clin Geriatr Med 17:661–672
Pope FM (1970) Parasitophobia as the presenting symptom of vitamin B12 deficiency. Practitioner 204:421–422
Reis PJ, Tunks DA, Sharry LF (1973) Plasma amino acid patterns in sheep receiving abomasal infusions of methionine and cystine. Aust J Biol Sci 26:635–644
Riedel-Baima B, Riedel A (2008) Female pattern hair loss may be triggered by low oestrogen to androgen ratio. Endocr Regul 42(1):13–16
Ringa V (2000) Menopause and treatments. Qual Life Res 9(6):695–707
Rossouw JE, Anderson GL, Prentice RL et al (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women’s Health Initiative randomized controlled trial. JAMA 288 (3): 321–333
Rubin CD, Reed B (1996) Twenty four hour growth hormone secretion in a patient with Werner’s syndrome. Exp Gerontol 31:557–561
Rushton DH (2002) Nutritional factors and hair loss. Clin Exp Dermatol 27:396–404
Rushton DH, Dover R, Sainsbury AW, Norris MJ, Gilkes JJ, Ramsay ID (2002) Iron deficiency is neglected in women’s health. Br Med J 325:1176
Rushton DH, Ramsay ID (1992) The importance of adequate serum ferritin levels during oral cyproterone acetate and ethinyl oestradiol treatment of diffuse androgendependent alopecia in women. Clin Endocrinol 36:421–427
Rushton DH, Ramsay ID, James KC, Norris MJ, Gilkes JJ (1990) Biochemical and trichological characterization of diffuse alopecia in women. Br J Dermatol 123: 187–197
Sadick NS (1993) Clinical and laboratory evaluation of AIDS trichopathy. Int J Dermatol 32(1):33–38
Sawin CT, Geller A, Herschman JE (1979) The aging thyroid: increased prevalence of elevated serum TSH levels in the elderly. JAMA 242:247–250
Schell H, Kiesewetter F, Seidel C, von Hintzenstern J (1991) Cell cycle kinetics of human anagen scalp hair bulbs in thyroid disorders determined by DNA flow cytometry. Dermatologica 182(1):23–26
Schrier SL (2003) Causes and diagnosis of anemia due to iron deficiency. Available from: www.UpToDate.com Last updated November 6
Sinclair R (2002) There is no clear association between low serum ferritin and chronic diffuse telogen hair loss. Br J Dermatol 147:982–984
Taylor S, Hyler SE (1993) Update on factitious disorders. Int J Psychiatr Med 23:81–94
Thornton MJ (2002) The biological actions of estrogens on skin. Exp Dermatol 11(6):487–502
Tran D, Sinclair RD, Schwarer AP, Chow CW (2000) Permanent alopecia following chemotherapy and bone marrow transplantation. Austral J Dermatol 41: 106–108
Trost LB, Bergfeld WF, Calogeras E (2006) The diagnosis and treatment of iron deficiency and its potential relationship to hair loss. J Am Acad Dermatol 54: 824–844
Trüeb RM (2007) Chemotherapy-induced anagen effluvium: diffuse or patterned? Dermatology 215(1):1–2
Trüeb RM (2008) Diffuse hair loss. In: Blume-Peytavi U, Tosti A, Whiting DA, Trüeb R. Hair growth and disorders. Springer, Berlin
Venning VA, Dawber RP (1988) Patterned androgenetic alopecia in women. J Am Acad Dermatol 18:1073–1077
Vowels M, Chan LL, Giri N et al (1993) Factors affecting hair regrowth after bone marrow transplantation. Bone Marrow Transpl 12(14):347–350
Waalen J, Felitti V, Beutler E (2002) Haemoglobin and ferritin concentrations in men and women: cross sectional study. BMJ 325:137
Wang J, Lu Z, Au JLS (2006) Protection against chemotherapy-induced alopecia. Pharm Res 23:2505–2514
Wilde O The picture of Dorian Gray. Penguin Popular Classics, London
Williams RH (1947) Thyroid and adrenal interrelations with special reference to hypotrichosis axillaries in thyrotoxicosis. J Clin Endocrinol 7:52–57
Wolff JL, Starfield B, Anderson G (2002) Prevalence, expenditures, and complications of multiple chronic conditions in the elderly. Arch Intern Med 162(20):2269–2276
Wykoff RF (1987) Delusions of parasitosis: a review. Rev Infect Dis 9:433–437
Yoshimura K, Nakano H, Yokoyama K, Nakayama M (2005) Clin Exp Nephrol 9(2):158–163
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Trüeb, R.M. (2010). Age-Related General Problems Affecting the Condition of Hair. In: Trüeb, R., Tobin, D. (eds) Aging Hair. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-02636-2_15
Download citation
DOI: https://doi.org/10.1007/978-3-642-02636-2_15
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-02635-5
Online ISBN: 978-3-642-02636-2
eBook Packages: MedicineMedicine (R0)